CPI Aerostructures heads into its May 14 Q1 earnings call with two competing storylines: short sellers have been unwinding positions at pace, while a fresh equity offering threatens to dilute holders at a difficult moment for the stock.
The dominant move in the lending market this week has been a sharp pullback by shorts. Short interest dropped 42% over the week to roughly 0.64% of the free float — a low level in absolute terms, and the unwinding has been striking in speed. The position peaked around 160,000–194,000 shares short through early April, then collapsed back toward 84,000 by April 28. Borrow costs remain modest at 1.83% annualised, down about 8% on the week, and availability is extremely loose at over 2,100% of outstanding short interest — meaning the lending pool is nowhere near strained. With availability that wide and an ORTEX short score of 29.8 (down from 34 a week ago), there is no sign of squeeze pressure. Shorts are covering into what looks like a quiet exit.
The more pointed development came on April 14, when the company entered an at-the-money equity offering agreement with Craig-Hallum Capital Group, registering up to $17 million of common stock for potential sale. For a company with a market cap of roughly $47 million, that represents a substantial dilution ceiling. The 10-K/A amendment filed in early April also signals that the annual reporting process has required revision — context worth holding alongside the upcoming Q1 print. The stock has lost about 9.5% over the past month and closed at $3.61 on April 28.
Analyst coverage is effectively absent in any actionable sense. The most recent rating change on record dates to early 2020, when Canaccord Genuity downgraded from Buy to Hold. The $4.00 mean price target on file is from 2021 and carries no weight at current prices — the data is too old to inform positioning.
Options positioning tilts heavily defensive. The put/call ratio is running at 6.26, well above its 20-day average of 4.9, though the z-score of around 1.0 means this is elevated but not extreme relative to recent history. Notably, the PCR touched 7.1 — the 52-week high — on April 23, right as short interest was still near its recent peak. Both gauges have eased since, but options traders remain cautious. The closest listed peer, ISSC, fell 4.3% on the day and 2.4% on the week; LOAR was down 2.9% on the day and 9.1% on the week. CVU's 2.6% weekly gain stands out positively against that sector backdrop.
Institutional ownership is thin and concentrated. John Rudolf holds 7.1% of shares with no reported change, while Vanguard added a modest 14,620 shares through March 31 and Dimensional added 7,000. Kornitzer Capital built a new position of 127,300 shares by year-end 2025. CEO Dorith Hakim sold 9,648 shares in June 2025 at $3.04 — the stock is now higher at $3.61 — while board members Bond Carey and others have made small open-market purchases at prices between $2.70 and $3.37 over the past two years, reflecting incremental board-level conviction without anything material in scale.
The last earnings print on March 31 saw the stock fall 8.6% on the day and 12.9% over the following five days — the sharpest post-earnings reaction in the recent history on file. The May 14 release is therefore the immediate calendar focus, with the ATM overhang and the amended 10-K providing the backdrop against which the Q1 numbers will be read.
See the live data behind this article on ORTEX.
Open CVU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
